{"id":8294,"date":"2016-07-14T16:02:05","date_gmt":"2016-07-14T16:02:05","guid":{"rendered":"\/articles\/?p=8294"},"modified":"2016-07-14T16:14:37","modified_gmt":"2016-07-14T16:14:37","slug":"arch-therapeutics-inc-otcmktsarth-sliding-down","status":"publish","type":"post","link":"\/articles\/arch-therapeutics-inc-otcmktsarth-sliding-down\/","title":{"rendered":"Arch Therapeutics Inc (OTCMKTS:ARTH) Sliding Down"},"content":{"rendered":"<p>tags: ARTH <\/p>\n<p><img decoding=\"async\" style=\"color: #000000; font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 11px; float: right;\" src=\"\/\/s.hotstocked.com\/hotstocked.com\/repository\/articles\/93\/93918\/arth_6m_450x350.png\" border=\"0\" \/>The stock of Arch Therapeutics Inc (OTCMKTS:<a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=ARTH\">ARTH<\/a>) has really had a great run since it started climbing the charts back in the beginning of March. The ticker managed to gain quite a lot of value and keep it, before embarking on another upward climb in the middle of last month.<\/p>\n<p>&nbsp;<\/p>\n<p>The company&rsquo;s market cap has risen well above $85 million, which is right up there with some of the other more promising OTC marketplace entities. Still, <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=ARTH\">ARTH<\/a>&rsquo;s<\/strong> balance sheet is decent, but not as good as some of the other medical device companies out there. Here is a quick example of some of the contents of its latest financial filing.<\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li>cash: $1.67 million<\/li>\n<li>current assets: $1.76 million<\/li>\n<li>current liabilities: $399 thousand<\/li>\n<li>revenues: ZERO<\/li>\n<li>net loss: $1.22 million<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>Those numbers are certainly not bad, but it&rsquo;s kind of surprising that they are capable of providing so much uplift for <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=ARTH\">ARTH<\/a>,<\/strong> while the company itself hasn&rsquo;t issued a press release for a little over a month now.<\/p>\n<p>&nbsp;<\/p>\n<p>The latest upward run was pretty impressive, but it finally came to an end before the weekend and <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=ARTH\">ARTH<\/a><\/strong> began to slip down the charts. The latest session cost the ticker 8.33% of its value and we saw it close at $0.76125, while a total of 1.44 million traded shares generated $1.1 million in daily dollar volume, making it one of the most heavily traded stocks in yesterday&rsquo;s session.<\/p>\n<p>&nbsp;<\/p>\n<p>After a bit of hesitation in early trading today <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=ARTH\">ARTH<\/a><\/strong> is, once again, strongly headed in a downward direction, so it would be best if you do your due diligence and weigh out all the risks before making any trading or investment decisions.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>tags: ARTH The stock of Arch Therapeutics Inc (OTCMKTS:ARTH) has really had a great run since it started climbing the charts back in the beginning of March. The ticker managed to gain quite a&#46;&#46;&#46;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-8294","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/8294","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/comments?post=8294"}],"version-history":[{"count":0,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/8294\/revisions"}],"wp:attachment":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/media?parent=8294"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/categories?post=8294"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/tags?post=8294"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}